Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer

Fig. 3

RAME inhibits S6K1 signaling by blocking interaction with mTOR. a Immunoblotting analysis and quantification graphs of HeLa cells treated with each concentration of RAME for 24 h. b Immunoblotting analysis and quantification graphs of HeLa cells treated with RAME (80 μM) for each time. c Immunoblotting analysis of HeLa (left) and SiHa (right) cells treated with RAME (40, 80 μM) for 24 h. d Co-IP analysis and a quantification graph using an anti-IgG and S6K1 antibody in DMSO and RAME treated HeLa cells

Back to article page